From: Value of peripheral blood eosinophil markers to predict severity of asthma
Patient characteristics | Asthma Severity | p-value | |
---|---|---|---|
Mild (n = 457) | Moderate-to-severe (n = 687) | ||
N (%) | N (%) | ||
Gender | |||
Female | 312 (68.27) | 499 (72.63) | 0.116 |
Race | |||
White | 222 (48.58) | 340 (49.49) | 0.821 |
Black | 59 (12.91) | 81 (11.79) | |
Hispanic | 109 (23.85) | 155 (22.56) | |
Other/Unknown | 67 (14.66) | 111 (16.16) | |
Age groups | |||
12–17 years | 80 (17.51) | 36 (5.24) | <0.0001 |
18–35 years | 78 (17.07) | 113 (16.45) | |
36–64 years | 232 (50.77) | 401 (58.37) | |
Greater than/equal to 65 years | 67 (14.66) | 137 (19.94) | |
Top 5 Comorbidities | |||
Diabetes | 53 (11.60) | 107 (15.57) | 0.057 |
Cancer/tumor | 35 (7.66) | 38 (5.33) | 0.149 |
Congestive Heart Failure | 23 (5.03) | 45 (6.55) | 0.288 |
Cerebrovascular disease | 13 (2.84) | 19 (2.77) | 0.937 |
Renal disease | 8 (1.75) | 20 (2.91) | 0.213 |
CCI Score Mean (SD) | 1.49 (1.16) | 1.52 (1.14) | 0.701 |